Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Raloxifene hydrochloride
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Raloxifene 60mg tablets
0604011X0AAAAAA
|
Raloxifene hydrochloride | Raloxifene hydrochloride | Endocrine System | 12,042 |
|
Evista 60mg tablets
0604011X0BBAAAA
|
Evista | Raloxifene hydrochloride | Endocrine System | 115 |
|
Evirex 60mg tablets
0604011X0BFAAAA
|
Evirex | Raloxifene hydrochloride | Endocrine System | No data available |
|
Ostiral 60mg tablets
0604011X0BEAAAA
|
Ostiral | Raloxifene hydrochloride | Endocrine System | No data available |
|
Razylan 60mg tablets
0604011X0BDAAAA
|
Razylan | Raloxifene hydrochloride | Endocrine System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.